Quick Answer
CORCEPT THERAPEUTICS INC reported Diluted EPS of $0.82 per share for fiscal year 2025.
CORCEPT THERAPEUTICS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.82 | -33.3% |
| 2024 | $1.23 | +30.9% |
| 2023 | $0.94 | +8.0% |
| 2022 | $0.87 | -2.2% |
| 2021 | $0.89 | +4.7% |
| 2020 | $0.85 | +10.4% |
| 2019 | $0.77 | +28.3% |
| 2018 | $0.60 | -42.3% |
| 2017 | $1.04 | +1385.7% |
| 2016 | $0.07 | +216.7% |
| 2015 | -$0.06 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.16 | -61.0% | -44.8% |
| June 30, 2025 | $0.29 | -9.4% | +70.6% |
| March 31, 2025 | $0.17 | -32.0% | -58.5% |
| September 30, 2024 | $0.41 | +46.4% | +28.1% |
| June 30, 2024 | $0.32 | +28.0% | +28.0% |
| March 31, 2024 | $0.25 | +78.6% | -10.7% |
| September 30, 2023 | $0.28 | -6.7% | +12.0% |
| June 30, 2023 | $0.25 | +4.2% | +78.6% |
- CORCEPT THERAPEUTICS INC showed a decrease of -33.3% in Diluted EPS compared to the prior fiscal year.
- Over the 2015–2025 period, CORCEPT THERAPEUTICS INC’s diluted eps has grown by 1466.7% (from $0.06 per share (loss) to $0.82 per share).
- The most recent figure is from CORCEPT THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: